Regencell Bioscience Holdings (Regencell Bioscience Holdings) Operating Cash Flow per Share : $0.00 (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Operating Cash Flow per Share?

Regencell Bioscience Holdings's operating cash flow per share for the six months ended in Jun. 2023 was $0.00. Regencell Bioscience Holdings's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -87.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Regencell Bioscience Holdings's Operating Cash Flow per Share or its related term are showing as below:

RGC' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -136.7 Med: -112 Max: -87.3
Current: -87.3

During the past 5 years, Regencell Bioscience Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was -87.30% per year. The lowest was -136.70% per year. And the median was -112.00% per year.

RGC's 3-Year OCF Growth Rate is ranked worse than
98.51% of 805 companies
in the Drug Manufacturers industry
Industry Median: 7.8 vs RGC: -87.30

Regencell Bioscience Holdings Operating Cash Flow per Share Historical Data

The historical data trend for Regencell Bioscience Holdings's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Operating Cash Flow per Share Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

-0.03

-0.06

-0.41

-0.38

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Operating Cash Flow per Share	Get a 7-Day Free Trial				-0.03	-	-	-	-

Competitive Comparison of Regencell Bioscience Holdings's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's Price-to-Operating-Cash-Flow falls into.

Regencell Bioscience Holdings Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Regencell Bioscience Holdings's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	-4.963	/	13.013
	=	-0.38

Regencell Bioscience Holdings's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	0	/	13.013
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00

Regencell Bioscience Holdings Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.